BSG Annual Meeting 2020 – postponed to Feb 2021
- ACC Liverpool, Liverpool, L3 4FP
- 8:00 am - 5:00 pm
Last Updated on
It is with great regret that we have taken the decision to postpone this event. Many of our speakers work with immunocompromised liver patients and as such, have been requested to avoid conferences and unnecessary travel by their trusts, so we feel the best option is to postpone the event until the Autumn.
This will be a one-day monothematic event highlighting optimal patient pathways, top tips in optimising modifiable patient factors and current and future treatment options. The target audience for this event is consultant gastroenterologists, trainees, specialist nurses and allied health professionals.
The first session of the day will investigate the current impact of NAFLD on the NHS, with a focus on the scale of obesity and the challenge of multi-morbidity in the UK. As the day progresses delegates will hear talks on assessing liver fibrosis optimising their patients, and treatment endpoints in NAFLD. We will close the day by taking a look at emerging pharmacotherapies for NAFLD.
This event is sponsored by Norgine, Allergan and Intercept Pharma.